PureCycle (PCT) Q2 2026 earnings review
Survival Secured, But Commercial Reality Lags The Rhetoric
PureCycle management continues to frame 2026 as a massive 'inflection point', yet the financials reflect a company still heavily in its developmental infancy. Revenue grew for the sixth consecutive quarter, reaching $4.5M, but remains eclipsed by a $31M quarterly cash burn (operations + materials). Production volumes actually reversed sequentially—from 8.4M lbs in Q1 to 4.5M lbs in Q2—due to a planned turnaround. The most significant achievement this quarter wasn't commercial, but financial: a $432M net capital raise saved the balance sheet, retiring toxic 7.25% notes and providing $236.9M in total liquidity. The runway is now secure, but the commercial execution clock is ticking loudly.
🐂 Bull Case
The June concurrent offering (convertibles + common stock) fundamentally de-risked the company. Retiring $216M in short-term green bonds and boosting liquidity to $236.9M gives PureCycle the runway needed to execute its commercial ramp and negotiate project financing from a position of strength.
Macro tailwinds are accelerating. The New Jersey recycled-content approval (mid-May) and California's SB54 are forcing major brands to adopt PCR. With 17 active trials tied explicitly to New Jersey compliance, regulatory mandates are shifting PureCycle's product from a 'nice-to-have' to a legal requirement.
🐻 Bear Case
Ironton's nameplate capacity is 107M lbs/year. Q2 production was 4.5M lbs (an 18M lb annualized run-rate). Even accounting for the planned turnaround, the gap between theoretical capacity and actual throughput remains massive, casting doubt on unit economics.
Management targets Ironton breakeven in the second half of 2026, but with Q2 net losses of $142M and negative adjusted EBITDA of $31.7M, the required commercial ramp to achieve cash-flow neutrality is staggeringly steep.
⚖️ Verdict: ⚪
Neutral. The massive recapitalization removes the immediate existential threat, but the core business model—producing recycled resin at a scale and cost that justifies the massive CapEx—remains unproven on the P&L.
Key Themes
Brand Conversions Escaping the Lab
After quarters of 'painstakingly slow' qualifications, tier-1 customers are entering commercial production. First commercial resin deliveries to P&G began in Q2 for Downy detergent caps. Tide caps are scheduled for Q3, and Vicks ZzzQuil lids for Q4. In the QSR space, compounded product shipped to all three major converters for cold cup trials. These high-visibility wins serve as crucial validation for the remaining ~180 opportunities in the pipeline.
On-Site Compounding Unlocks Margin and TAM
The successful commissioning of the Ironton on-site compounding facility is a game-changer. PureCycle is no longer just selling base resin; it is selling application-ready compounds. Running 24/5 (scaling to 24/7 in Q4), the unit produced ~2.0M lbs in Q2. This allows PureCycle to meet strict customer specifications for clear thermoformed packaging and film, segments where they hold a near-monopoly on food-grade quality.
Macro: Regulatory Deadlines Force the Issue
The macro narrative is rapidly converting into hard sales. The New Jersey approval acts as a catalyst, given the state's food-contact exemption expires in January 2027 and recycled-content requirements rise to 20%. Thermoformed packaging used by QSRs is directly impacted, explaining the sudden surge in active customer trials (69 active, +15 in Q2). PureFive is also now APR certified, satisfying California SB54 mandates.
Production Volatility Reversing Progress
Reversing trend. PureFive production fell from 8.4M lbs in Q1 to 4.5M lbs in Q2. While management attributes this to a planned turnaround (which was completed under budget and ahead of schedule), the reality is that the plant is still operating at a fraction of its 107M lb capacity. Over 170 reliability projects were executed; if these do not result in a dramatic, sustained step-function increase in H2 production, the core technology's scalability will be heavily scrutinized.
Thailand Financing Remains a Moving Target
Despite receiving Thailand Board of Investment approval (including 'Fast Pass'), the ~$250M project financing remains unresolved. Management is currently 'negotiating binding terms' with a target of year-end close. Until this financing is locked, the company's timeline for operationalizing the facility in 2028 carries heavy execution and capital risk.
Cash Burn Eclipses Revenue Growth
While revenue sequentially accelerated to $4.5M, the cost structure is brutal. Core monthly operations spending is $8.3M, plus $2.1M for materials (feedstock/virgin PP). This equates to over $31M in quarterly cash out the door just to run the business, generating a staggering negative operating leverage profile in the near term.
Other KPIs
Reversing trend from depletion to strength. Driven by a massively dilutive but necessary recapitalization (issuing $287.5M in 4.75% convertibles and 19.8M common shares). The net proceeds of $432M allowed the company to repurchase $216M in maturing 7.25% notes, effectively shifting the debt burden to 2032 and saving the company from a near-term liquidity crisis.
Stable but deeply negative. The slight degradation vs the -$27.8M reported in Q2 2025 masks a $4.3M improvement in pure operating loss, distorted by lower non-cash add-backs (equity-based compensation and equipment write-downs) year-over-year.
Stable YoY, but heavily burdened by below-the-line items, including a $34.5M loss on the extinguishment of debt (from retiring the green bonds) and a $52.5M non-cash change in warrant valuation. Q2 cash outflows also took a hit from a $20.4M non-recurring legal settlement.
Guidance
Accelerating from previous guidance of $39 - $45 million. First-half spend was already $35M, primarily related to the Ironton turnaround and compounding commissioning. Second-half spend of $10-$12M is contingent on 'project gating decisions', reflecting a tighter grip on discretionary capital until Thailand financing is secured.
Decelerating sharply. With the bulk of the 7.25% green notes retired, the remaining debt service reflects only the August coupon on the $34M stub notes and final equipment financing payments, drastically improving Q3 cash flow dynamics.
Key Questions
Ironton Breakeven Math
You maintain a target of site-level cash breakeven at Ironton in the second half of 2026. Given the current operations/materials spend of ~$10.4M per month, what exact monthly volume and price realization are required to hit that bogey?
Production Post-Turnaround
With 170+ reliability projects completed and the CP2/mechanical seal constraints supposedly fixed, what is the expected average daily production rate for Q3, and what remains the primary bottleneck to reaching the 107M lb nameplate capacity?
Thailand Financing Risk
If project financing for the $250M Thailand facility is delayed past year-end, what is the backup plan? Will corporate cash be deployed to maintain the construction timeline, or will the project be paused?